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ABSTRACT
Objective: Vascular EhlerseDanlos syndrome (vEDS)
is a rare genetic condition related to mutations in the
COL3A1 gene, responsible of vascular, digestive and
uterine accidents. Difﬁculty of clinical diagnosis has
led to the design of diagnostic criteria, summarised in
the Villefranche classiﬁcation. The goal was to assess
oral features of vEDS. Gingival recession is the only
oral sign recognised as a minor diagnostic criterion.
The authors aimed to check this assumption since
bibliographical search related to gingival recession in
vEDS proved scarce.
Design: Prospective caseecontrol study.
Setting: Dental surgery department in a French tertiary
hospital.
Participants: 17 consecutive patients with genetically
proven vEDS, aged 19e55 years, were compared with
46 age- and sex-matched controls.
Observations: Complete oral examination (clinical and
radiological) with standardised assessment of
periodontal structure, temporomandibular joint
function and dental characteristics were performed.
COL3A1 mutations were identiﬁed by direct
sequencing of genomic or complementary DNA.
Results: Prevalence of gingival recession was low
among patients with vEDS, as for periodontitis.
Conversely, patients showed marked gingival fragility,
temporomandibular disorders, dentin formation
defects, molar root fusion and increased root length.
After logistic regression, three variables remained
signiﬁcantly associated to vEDS. These variables were
integrated in a diagnostic oral score with 87.5% and
97% sensitivity and speciﬁcity, respectively.
Conclusions: Gingival recession is an inappropriate
diagnostic criterion for vEDS. Several new speciﬁc oral
signs of the disease were identiﬁed, whose
combination may be of greater value in diagnosing
vEDS.
INTRODUCTION
Vascular EhlerseDanlos syndrome (vEDS
OMIM#130050) is a rare genetic condition
with an estimated prevalence of 1/150000.
1
Its clinical course is the most severe among
the EhlerseDanlos syndromes (EDSs). The
inheritance of vEDS follows an autosomal
dominant trait and is related to mutations in
the COL3A1 gene, encoding the pro-a (1)
chain of type III procollagen.
1 The mutation
typically alters the assembly, stability and thus
secretion and resistance to tensile stress of
this ﬁbrillar collagen, resulting in early
spontaneous arterial, digestive and obstet-
rical accidents. Over 250 different mutations
have been described in the COL3A1 gene,
typically either missense mutations affecting
a glycine residue, splicing mutations or rare
exonic deletions.
2 No genotypeephenotype
correlations have been evidenced, except for
haploinsufﬁciency, which may be charac-
terised by a consistently milder phenotype.
3
Oral involvement is frequently present in
patients with vEDS, even in early adulthood,
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ARTICLE SUMMARY
Article focus
- To provide physicians with an in-depth descrip-
tion of oral involvement of patients with vEDS.
- To evaluate speciﬁcity of gingival recession,
a minor diagnostic criterion for vEDSin the
Villefranche classiﬁcation.
Key messages
- Prevalence of gingival recession and periodon-
titis was low among patients with vEDS.
- Conversely, patients showed marked gingival
fragility, temporomandibular joint disorders,
dentin formation defects, molar root fusion and
increased root length.
- Several new speciﬁc oral signs of this disease
were identiﬁed, whose combination may be of
greater diagnostic value.
Strengths and limitations of this study
- All screened patients had genetically conﬁrmed
vEDS.
- Limited sample size, sex ratio imbalance, pre-
adult patients were not included. Validation
studies are necessary.
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Open Access Researchdescribed as gingival recession.
4 This oral sign of the
disease, despite being part of the minor diagnostic
criteria of the Villefranche classiﬁcation
4 remains poorly
documented and no in-depth description of the
proposed occurrence of gingival recession in the vEDS
diagnostic criteria was found in previously published
reports.
In this study, we aimed to reassess oral involvement in
a cohort of patients with molecularly proven vEDS (ie,
with proven COL3A1 mutations). We hypothesised that
a systematic assessment of dental, gingival and osteo-
articular characteristics of these patients would show
signiﬁcant differences with age- and sex-matched
controls.
METHODS
Study design
This study was designed according to guidelines of the
STROBE statement. Consecutive patients with molecu-
larly proven vEDS and healthy volunteers were prospec-
tively included in a monocentric caseecontrol study.
Each patient was appointed for a routine dental visit.
Detailed standardised clinical records on teeth and
surrounding soft tissues were made by a senior dental
surgeon. Most of the time, physicians were aware of the
patient’s diagnostic status upon inclusion except for
patients that were in diagnostic work-up with genetic
testing in progress. Standardised dental x-rays were
performed for each subject which included periapical
x-rays of the upper and lower jaws for detection of root
and surrounding bone structure, positional assessment
of emerged and emerging teeth and temporomandib-
ular joint (TMJ) imaging by orthopantomogram (OPG).
Intra-oral pictures were made for all patients. All exam-
inations were performed for clinical care and diagnostic
purpose.
Study population
Patients with genetically diagnosed vEDS from the
Centre de Re ´fe ´rence des Maladies Vasculaires Rares
(Ho ˆpital Europe ´en Georges Pompidou, Assistance
Publique des Ho ˆpitaux de Paris, Paris, France), the
French National Referral Centre for patients with vEDS,
were sent to the Dental Department of Albert Chenevier
Henri-Mondor University Hospital for dental care.
Patients with suspected vEDS referred for dental status
assessment without mutation in the COL3A1 gene were
excluded of the study after screening. The control group
was constituted by random inclusion of consecutive
healthy subjects that consulted the dental department
for clinical care. Control subjects had no medical history,
especially no suspicion of connective tissue disorder and
were referred for general dentistry purposes. Patients of
the control group were age and sex matched with the
vEDS patients in a ratio close to 3 to 1. To limit the
possibility of confounders of gingival bleeding or
temporomandibular disorders, three common oral
indexes were measured at baseline: plaque index,
gingival index and decayed/missing/ﬁlled teeth index.
Medical and genetical data
Patients included in this study were clinically assessed
by senior physicians of the French referral centre for
rare vascular diseases (see above). Patient history and
clinical characteristics of vEDS were systematically
assessed by a standardised observation. Number and type
of vascular, digestive and uterine complications were
recorded. Major and minor clinical diagnostic criteria
were staged according to the Villefranche classiﬁcation.
4
Genomic DNA was obtained by saline extraction from
whole blood leucocytes. The COL3A1 gene was then
analysed by direct sequencing as previously described.
5
In case of negative direct DNA sequencing, patients
were screened for exon skipping by ﬁbroblast culture,
RNA extraction, reverse transcription and PCR and
direct sequencing.
5 All patients gave written informed
consent. Mutations are described according to the
nomenclature recommended by the Human Genome
Variation Society. DNA mutation numbering was based
on COL3A1 human complementary DNA sequence
(GenBank NM_000090.3).
Oral examination
Periodontal status
The periodontal data consisted in standardised
measurement of gingival fragility, thickness, recession
and surface texture. Fragility and bleeding tendency was
assessed by a periodontal probe and staged according to
Loe classiﬁcation.
6 History of gingival bleeding and its
frequency during tooth brushing as described by the
patient was recorded. Gingival thickness was measured
by the ability to see the graded periodontal probe
through gingival tissue.
7 Recessions of the gingival
margin in respect of the cementoenamel junction were
measured at six different sites per tooth. The gum
surface texture (stippling) was assessed visually and
evaluated qualitatively. Diagnosis of periodontitis was
checked clinically and radiologically. Periodontal
pockets were evaluated by probing, and alveolar bone
level was assessed by x-rays in order to detect horizontal
and angular bone loss.
Dental status
Teeth were clinically and radiologically assessed for
structural abnormalities and secondary lesions (decay,
traumatic injury.), as well as root fusion and pulp
volume, deﬁned by the pulp to crown area ratio as
measured on retroalveolar x-rays. Root length of
mandibular teeth was deﬁned as normal when stopping
before the upper limit of the mandibular canal, which is
easily visible on the OPG, and as long when crossing it.
TMJ status
History of oro-facial pain originating either from the
masticatory muscles or the joint capsula was recorded,
including reports of pain in the jaw, temples, face,
pre-auricular area or the TMJ both at rest and in func-
tion. Physical examination included the observation
and measurements of mandibular motion (maximal
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palpation of the masticatory muscles (masseter, tempo-
ralis, medial and lateral pterygoid muscles) and static
and dynamic TMJ palpation. During mandibular
motions, noises were staged as follows: ‘clicking’,
‘popping’ as a consequence of disk displacement and
‘crunching’, ‘grating’ and/or ‘grinding’ as a conse-
quence of osteoarthritis. Joint surfaces were studied on
OPGs, in search of extensive ﬂattening or sclerosis of the
articular surfaces. TMJ disorders were then staged
according to validated international guidelines
(Research Diagnostic Criteria for Temporo-Mandibular
Disorders, RDC/TMD) as previously described by
Dworkin and LeResche.
8 Brieﬂy, three groups are
individualised by this classiﬁcation: muscle disorders
(group 1), disk displacements (group 2) and arthralgia/
arthritis/arthrosis (group 3). These clinical indicators
allow a stratiﬁcation of TMD for each subject, for each
group may be present separately or in association with
one other.
Statistical analysis
Descriptive statistics used numbers and percentages for
qualitative variables and median and inter-quartiles
ranges intervals for quantitative ones. The comparison
between groups was performed using c
2 tests or Fisher’s
exact tests for qualitative variables and two-sample
Wilcoxon tests for quantitative ones. Variables with a
p value <0.10 in the ﬁrst step were then entered in
a stepwise logistic regression. Variables with a p value
<0.06 using the Wald test were retained in the ﬁnal
model. A simpliﬁed diagnostic score with ﬁve levels was
built from the results of the logistic model. The receiver
operating characteristic curve of this simpliﬁed diag-
nostic score was computed, a threshold was determined
and sensitivity and speciﬁcity were evaluated using this
threshold, with their exact 95% CIs. All the tests were
two sided, with a p value considered signiﬁcant when
<0.05. All the computations were performed using the
SAS V.9.2 statistical package (SAS Institute Inc.).
RESULTS
Participants
Between November 2009 and June 2011, 27 consecutive
patients with suspected or conﬁrmed vEDS were referred
for dental examination. Patients without genetic conﬁr-
mation of vEDS (n¼6) were not considered eligible for
participation. Of the 21 remaining patients, four
declined participation and 17 were ﬁnally included
(ﬁgure 1). In one patient, OPG was unavailable and
therefore excluded from the design of the oral score.
Control subjects (n¼68) were screened for an inclusion
ratio of 3 to 1. Five subjects declined participation and
17 were considered ineligible for medical reasons (ie,
pregnancy, diabetes.) or dental status (full edentulous
or severe periodontitis), leaving 46 controls that
completed the study. Baseline characteristics of vEDS
patients and controls are shown in table 1. Dental
status of vEDS and control patients were equivalent as
shown by the decayed/missing/ﬁlled teeth index. The
Figure 1 Flow chart.
- 13 were 
excluded for 
medical reasons  
- 4 were 
excluded for 
dental reasons 
-5 declined 
participation 
- 6 moleculary 
unproven vEDS 
- 4 declined 
participation 
27 patients were screened  68 patients were screened 
vEDS group  Control group 
-16 complete clinical and 
radiographical follow-up 
assessment 
-1 complete clinical whitout 
radiographical assessment 
46 complete clinical and 
radiographical follow-up 
assessment 
Statistical analysis 
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Oral phenotype of vascular EhlerseDanlos syndromeplaque and gingival indexes, source of confounding
biases in speciﬁcity of gingival bleeding, did not differ
signiﬁcantly between both groups.
Periodontal status
Gingival recession was less frequent in patients (n¼7;
41.2%) than in controls (n¼31; 67.3%). Periodontitis
Table 1 Baseline characteristics of patients with vEDS and age- and sex-matched healthy controls
Variable
vEDS patients, n (%)
or median (Q1; Q3)
Controls, n (%)
or median (Q1; Q3) Univariate p value
N1 7 4 6
Age 33 (24; 44) 36 (25; 45) NS
Male 5 (29) 13 (28) NS
Periodontal features
Plaque index 30 (20; 54) 20 (13; 60) NS
Gingival index 1 (0; 1) 1 (0; 1) NS
Probing bleeding index 2 (1; 3) 1 (0; 1) 0.0003
Thinness 16 (94) 20 (43) 0.0003
Temporomandibular features
TMJ group 1 2 (12) 2 (4) NS
TMJ group 2 12 (71) 8 (17) <0.0001
TMJ group 3 10 (59) 3 (7) 3.10
 5
Total TMJ 14 (82) 11 (24) <0.0001
Pain 7 (41) 3 (100) NS
Dental features 15 (94) 23 (50) 0.0020
Pulp shape modiﬁcation 12 (75) 14 (30) 0.0019
Root fusion 8 (50) 9 (20) 0.0262
Exceeding root length 11 (69) 1 (2) 10
 7
DFMT 4 (2; 11) 7 (2; 9) NS
Plaque index is deﬁned by (number of tooth with plaque/total number of tooth) 3100. Gingival index is deﬁned by extent of gingival inﬂammation
and staged from 0 to 3. DMF-T index
9 is deﬁned by decayed, missing and ﬁlled teeth, and ranges from 0 to 28 according to number of diseased
teeth.
DMF-T, ‘decayed/missing/ﬁlled teeth index’; TMJ, temporomandibular joint; vEDS, vascular EhlerseDanlos syndrome.
Figure 2 Periodontal
characteristics of vascular
EhlerseDanlos syndrome (vEDS).
Both gingival and oral mucosa
appear very thin (A). Oral mucosa
showed signs of spontaneous
intramucosal bleeding as a likely
consequence of increased fragility.
Periodontal probing provoked
excessive gingival bleeding (B).
Assessment of gingival thinness
was made by measuring levels of
translucency on a scaled probe
(C). Papyraceous aspect of the
gingival tissue under periodontal
probe pressure and decreased
stippling (D). Comparison of
gingival thinness (E) and gingival
bleeding on probing (F) in patients
with vEDS and healthy controls.
****p<0.001.
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Oral phenotype of vascular EhlerseDanlos syndromewas present in 23.5% (n¼4) vEDS patients only when
compared with controls (n¼21; 45%). Presentation of
gingiva in vEDS patients was evocative of a particular
periodontal phenotype rather than common dental or
periodontal disease. This phenotype was characterised
by a generalised thinness of both gingiva and oral
mucosa and translucency of the gingiva with apparent
vasculature (ﬁgure 2A,C). Overall, increased gingival
thinness was present in 16 (94%) patients versus 20
(43.3%) controls. Gingival surface texture was also
evocative, with a decreased stippling and a papyraceous
aspect when pressuring the gum with the dental probe
(ﬁgure 2D). These characteristics were associated
with an increase in gingival fragility, as measured by
bleeding on probing during gingival thinness assessment
(ﬁgure 2B,F and table 1).
TMJ status
TMJ disorders were present in 14 (82%) patients with
vEDS and in 11 (24%) controls (p<0.0001) (table 1).
Almost half of patients (41%) described TMJ pain,
whereas it was reported in only three (6.5%) controls.
Pain originated from the masticatory muscles or the TMJ
itself (groups 1 and 3 in the TMD classiﬁcation
8) and
were described as a discomfort during mastication or
yawning. Seventy-one per cent of the vEDS patients
presented signiﬁcant intra-articular disc displacement
with reduction associated to clicking (group 2). Prema-
ture remodelling of the TM articular surfaces (ﬁgure 3B)
was present in seven of 16 (43.8%) patients, versus two
(4.3%) in controls (p¼0.0086). This last ﬁnding was
highly prevalent in vEDS patients, whereas it was
uncommon in controls.
Dental ﬁndings
Dental abnormalities observed in patients with vEDS were
related to defects in dentin formation rather than to
common dental pathology (table 1). x-Ray analysis
revealed a signiﬁcant reduction in pulp volume (ﬁgure
3C) secondary to progressive pulp obliteration by dentin
synthesis. Pulpar volume decreases physiologically with
ageing in the general population,
10 yet it was repeatedly
observed in young vEDS patients of this cohort. Further-
more, 75% of vEDS patients presented retraction of the
dental pulp shape versus 29.8% of controls (table 1).
Molar root fusion was also more frequently present,
particularly in the mandibular second molar (50%)
(ﬁgure 3D) when compared with controls (19.5%).
Mandibular dental root length was signiﬁcantly
increased in a large proportion of vEDS patients. Increased
root length was most often found on the second mandib-
ular molar (n¼11/16), whereas such an observation was
only exceptional in controls (n¼1/46), more rarely on
mandibular premolars or the ﬁrst molar. This sign is very
easily identiﬁable by any physician on the OPG (ﬁgure 3E).
Oral score
Three oral characteristics remained signiﬁcantly associ-
ated to vEDS after logistic regression: increased root
length, modiﬁed dental pulp shape and arthralgia/
arthrosis (TMJ disorder group 3). These variables were
staged into a diagnostic score according to results of the
logistic model (table 2): increased root length was
weighted 2 and the two remaining variables were
weighted 1. Signs were either present (scoring either 1 or
2) or not (scoring 0). The total score is the result of
adding weighted values of present signs. A score of 0 or 1
was considered negative and a score of 2 to 4 was
considered positive with a sensitivity and speciﬁcity of
0.878 95% CI (0.604 to 0.978) and 0.978 95% CI (0.870 to
0.999%), respectively (table 2 and supplemental data 2).
DISCUSSION
This case-control study is the ﬁrst speciﬁc report of oral
phenotype in patient with genetically conﬁrmed vEDS.
We evidenced that gingival recession may be an inap-
propriate diagnostic criterion of vEDS, whereas several
other original ﬁndings may be of greater diagnostic
value: increased dental root length, TMJ pain and
premature arthrosis and a decreased pulp to crown area
ratio. The ﬁrst two criteria are easily identiﬁable by any
physician on an OPG and on physical examination. The
A 
B 
D  E 
C 
Figure 3 Oral radiographic characteristics of vascular
EhlerseDanlos syndrome. An orthopantogram of a 30-year-old
patient shows original dental ﬁndings (A) as premature
remodelling of temporomandibular joints (B), decreased pulp
volume, a thistle-shaped pulp chamber (C), an increased
length of mandibular molar roots (D) and root fusion of the
second mandibular molar (E).
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Oral phenotype of vascular EhlerseDanlos syndromethird requires either a short-speciﬁc training on reading
retro-alveolar x-rays, or a speciﬁc, but simple evaluation
by a dental surgeon.
Oral mucosa and gingival thinness have to be consid-
ered as an aspect of the general phenotype of vEDS.
Indeed, typical skin involvement is marked by increased
thinness with consequent translucency
11 and by
increased fragility, illustrated by the occurrence of
extensive spontaneous haematomas and delayed papy-
raceous wound healing. A decreased intima-media
thickness of elastic arteries in vEDS may be another
phenotypic expression.
12 Similarly to the skin, type III
collagen is present in the gingival connective tissue
near the basement membrane and blood vessels.
11
Consequently, the disturbance of type III collagen
production/secretion by the gingival ﬁbroblast popula-
tion, besides the physical and thermal stress the gum is
exposed to and which may alter type III collagen,
13 may
explain in part the increase of gingival thinness
14 15 and
thus its fragility and bleeding tendency. Possible
involvement of type III collagen in platelet adhesion
would be a further precipitating factor for bleeding.
16
Dental abnormalities and particularly radicular
abnormalities as increased root length that has been
repeatedly evidenced in ours patients may be speciﬁc for
the disease. Indeed, this condition is exceptional in the
general population, so, its random ﬁnding would have
been unlikely in the vEDS group. Type III collagen is
necessary to type I collagen ﬁbrillogenesis.
17 Other
collagen gene mutations are reported to be associated
with oral and dental abnormalities: type I collagen chain
gene mutations are associated with type I dentinogenesis
imperfecta in the more general context of osteogenesis
imperfecta.
18 In this case, the teeth are speciﬁcally
Table 2 Oral signs signiﬁcantly associated to vascular EhlerseDanlos syndrome after logistic regression and the deducted
oral score
Variable Parameter estimate OR (95% CI) p Value
Intercept  4.7
TMJ-D group 3 3.4 29.5 (2.2 to 389.6) 0.0101
Pulp shape modiﬁcation 2.6 14.0 (1.0 to 193.8) 0.0488
Increased root length 5.5 256.1 (9.5 to >999.9) 0.0009
Oral score
A. TMJ group 3 No (0) Yes (1)
B. Pulp shape modiﬁcation No (0) Yes (1)
C. Exceeding root length No (0) Yes (2)
Oral score (A+B+C): if score ¼0 or 1, negative result and if score >1, positive result.
TMJ-D, temporomandibular joint disorder.
Table 3 Type of COL3A1 mutation, ﬁrst major complication and oral score of the 17 patients with vascular EhlerseDanlos
syndrome (vEDS)
Patient Age (years) Sex (M/F)
COL3A1 mutation First major
complication Oral score DNA Protein
1 49 F c.665G>A p.Gly222Asp U 4
2 30 F c.2285G>A p.Gly762Asp V NA
3 23 M c.575G>A p.Gly192Asp D 3
4 46 F c.575G>A p.Gly192Asp D 2
5 19 F c.1241G>T p.Gly414Val V 4
6 44 F c.647G>C p.Gly216Ala U 4
7 33 F c.1662+1G>A exon 23 skipping D 4
8 20 F c.3364 2A>G exon 46 skipping N 3
9 55 F c.755G>T p.Gly252Val U 4
10 20 F c.755G>T p.Gly252Val N 3
11 37 M c.952-106_996
+45delinsGCTTAA
exon 14 skipping V 2
12 40 F c.951+1G>A exon 13 skipping V 3
13 24 F c.1662+1G>A exon 23 skipping V 2
14 34 M c.2150G>A p.Gly717Asp V 2
15 24 F c.898 1G>C exon 13 skipping V 2
16 50 M c.2671G>A p.Gly891Arg V 0
17 29 M c.1330G>A p.Gly444Arg V 1
The independent oral variables associated to vEDS were integrated into an oral score and each signiﬁcant variable weighted according to the
signiﬁcance of the statistical association.
D, digestive; F, female; M, male; N, none; U, uterine; V, vascular.
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Oral phenotype of vascular EhlerseDanlos syndromeamber and translucent. Radiographically, the teeth have
short, constricted roots and dentine hypertrophy leading
to pulpal obliteration.
18 These diverse structural defects
highlight the key-role of ﬁbrillar collagens in mineral-
ised tissue formation. An abnormal type III collagen in
dental and articular tissues may also explain the dental
and TMJ abnormalities/disorders. Its presence within
dentin remains controversial, yet it has been evidenced
in the epithelio-mesenchymal interface during dentino-
genesis.
19 Finally, type III collagen has been evidenced in
the posterior region of disc attachments of the TMJ.
20
Previous studies have reported diverse oral signs in
EDS patients but none were speciﬁc to vEDS and none
were dedicated to a cohort of patients with molecularly
conﬁrmed vEDS.
21 The absence of genetic certainty is
a major selection bias as the disease may be confused with
other connective tissue diseases as non-vascular EDSs or
more recently evidenced LoeyseDietz syndrome.
11 Peri-
odontal or oral lesions were recorded in several studies
on patients with various non-vascular subtypes of EDS,
but no signiﬁcant association between oral signs and
EDS subtype could be evidenced.
22e26 The only study
reporting oral signs as a possible diagnostic tool in EDSs
was related to the classical (OMIM#130020) and hyper-
mobile (OMIM#130000 and OMIM#130010) types.
27 It
was suggested that absence of the inferior lingual and
labial frenulas were speciﬁc and sensitive signs for these
forms of EDS, yet these results have been subject to
controversy.
28 In our population sample, frenulas were
absent in approximately one-third of patients.
This study has several limitations. First, our analysis is
based on a small number of patients. However, this
limited population sample has to be considered in
respect of the rarity of vEDS, as it is to our best knowl-
edge the most important clinical study of oral involve-
ment of the disease. Second, the sex ratio is unbalanced
which may induce selection bias, notably for gingival
thinness that is more common in women in the general
population.
7 However, there is no evidence that oral signs
of vEDS identiﬁed by logistic regression may be inﬂu-
enced by sex ratio. Furthermore, patients were assigned
age- and sex-matched controls that may further limit any
residual bias. Finally, no children or teenagers were
included into this study. It is therefore not known if these
ﬁndings may apply to this speciﬁc age category, which is
of importance as typically the late teenage years match
with the onset of digestive and arterial accidents in vEDS.
The oral score we were able to design may be of
interest for clinical diagnosis of vEDS, especially as the
phenotype is usually discrete and as diagnosis may be
difﬁcult even for experienced physicians.
Given its high speciﬁcity and sensitivity if it were to be
conﬁrmed, its diagnostic value as a minor diagnostic
criterion as deﬁned by the Villefranche classiﬁcation
should be evaluated. A positive oral score associated with
one major vEDS sign may indicate genetic testing of the
COL3A1 gene with a good positive predictive value.
Further larger studies are necessary to determine the
exact diagnostic value of gingival thinness and bleeding
tendency in vEDS, as these signs were present in most
patients, yet not independent predictors in our analysis.
Considering the small number of vEDS patients, associ-
ations between mutation type and oral score were not
tested (table 3). But interestingly, the two patients with
a negative oral score had the same mutation type: an
arginine substitution for glycine (table 3). This obser-
vation needs further explorations.
In conclusion, our ﬁndings suggest that gingival
retraction, used in the Villefranche classiﬁcation, may be
an inappropriate diagnostic criterion for vEDS and that
increased root length, modiﬁed dental pulp shape and
premature wear of TMJ are signiﬁcantly associated to
vEDS. These ﬁndings, if conﬁrmed, may implement the
latter in a diagnostic oral score for vEDS.
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